MedCity News December 7, 2022
Katie Adams

Ekso Bionics — a company that makes exoskeleton bionic devices — recently acquired Parker Hannifin’s business unit for human motion and control for $10 million. The acquisition will help extend Ekso’s product line across the continuum of care and provides access to Vanderbilt University as a research partner.

Ekso Bionics — a San Rafael, California-based company that makes exoskeleton bionic devices — on Monday acquired Parker Hannifin’s business unit for human motion and control for $10 million. Parker is an Ohio-based manufacturer specializing in motion and control technologies. It received $5 million from Ekso at the deal’s closing, and it will receive the remaining $5 million over the next five years.

The acquisition will help extend Ekso’s product line across...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Neuronetics wins FDA clearance for device to treat adolescents with depression
J&J in talks to buy Shockwave Medical: WSJ
Roche develops continuous glucose monitor with predictive algorithms
MedCity Pivot: A Conversation About Wearable Robots with Scott Davis

Share This Article